FNCFX
Price
$2.54
Change
-$0.00 (-0.00%)
Updated
Sep 11 closing price
Net Assets
79.67B
RLBAX
Price
$39.98
Change
+$0.10 (+0.25%)
Updated
Sep 11 closing price
Net Assets
284.75B
Interact to see
Advertisement

FNCFX vs RLBAX

FNCFX vs RLBAX Comparison Chart in %
View a ticker or compare two or three
VS
FNCFX vs. RLBAX commentary
Sep 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FNCFX is a Hold and RLBAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBAX has more cash in the bank: 285B vs. FNCFX (79.7B). FNCFX pays higher dividends than RLBAX: FNCFX (5.38) vs RLBAX (1.12). FNCFX was incepted earlier than RLBAX: FNCFX (13 years) vs RLBAX (24 years). RLBAX (1.32) is less costly to investors than FNCFX (0.42). FNCFX is a more actively managed with annual turnover of: 62.14 vs. RLBAX (50.00). RLBAX has a lower initial minimum investment than FNCFX: RLBAX (250) vs FNCFX (1000000). FNCFX annual gain was more profitable for investors over the last year : 9.11 vs. RLBAX (5.83). FNCFX return over 5 years is better than : 33.96 vs. RLBAX (27.39).
FNCFXRLBAXFNCFX / RLBAX
Total Expense Ratio0.421.3232%
Annual Report Gross Expense Ratio0.421.3232%
Fund Existence13 years24 years-
Gain YTD6.3257.93580%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets79.7B285B28%
Annual Yield % from dividends5.381.12481%
Returns for 1 year9.115.83156%
Returns for 3 years34.5338.2190%
Returns for 5 years33.9627.39124%
Returns for 10 years87.7675.00117%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GSLIX18.770.15
+0.81%
Goldman Sachs Large Cap Value Instl
FBAKX35.310.18
+0.51%
Fidelity Balanced K
CREEX10.460.05
+0.48%
Columbia Real Estate Equity Inst
SMVLX100.180.26
+0.26%
Smead Value Investor
GOFIX27.69-0.18
-0.65%
GMO Resources III